Meyka Pro banner
Gelteq Limited Ordinary Shares

Gelteq Limited Ordinary Shares (GELS) Stock Overview

Explore Gelteq Limited Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

GELSNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.60
$0.03(5.17%)
U.S. Market is Open · 13:55

Gelteq Limited Ordinary Shares (GELS)

Meyka AI Score

Z

Key Financials

Market Cap5.2M
P/E Ratio-2.31
EPS (TTM)$-0.50
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$0.17
3 Months$0.15
1 Year Target$0.00

GELS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Gelteq Limited Ordinary Shares (NASDAQ: GELS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Gelteq Limited Ordinary Shares's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GELS on the NASDAQ shows an RSI of 47.21, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Gelteq Limited Ordinary Shares's NASDAQ-traded stock include a P/E ratio of -2.31 and a market capitalization of 5.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GELS on the NASDAQ.

Price Performance (NASDAQ: GELS)

1-Day Change
0.02%
5-Day Change
-2.16%
1-Month Change
8.69%
3-Month Change
32.73%
6-Month Change
-25.38%
Year-to-Date (YTD) Change
-28.68%
1-Year Change
-62.95%
3-Year Change
-80.59%
5-Year Change
-80.59%
All-Time (Max) Change
-80.59%

Contact Information

61 3 9087 3990
Monash Innovation Labs, G.60, 22 Alliance Lane, Clayton, VIC, 3800

Company Facts

180 Employees
IPO DateOct 29, 2024
CountryAU
Actively Trading

Frequently Asked Questions